Welcome to our dedicated page for Haleon SEC filings (Ticker: HLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Haleon’s separation from GSK created a consumer-health giant with dozens of power brands—and a web of disclosures that can overwhelm even seasoned analysts. Sales are broken out across oral care, pain relief, vitamins and more, while its first standalone Form 20-F runs hundreds of IFRS-heavy pages. If you have ever asked, "Where do I find Haleon insider trading Form 4 transactions" or "How do I decode Haleon’s quarterly earnings report 10-Q filing?", you know the challenge.
Stock Titan solves it. Our AI reads every new filing the moment it hits EDGAR, then delivers plain-English summaries, red-flags and searchable key terms. Whether you need Haleon Form 4 insider transactions in real-time, a side-by-side view of segment revenue from the latest 6-K, or want Haleon SEC filings explained simply, the platform highlights what matters: advertising spend trends, litigation provisions, post-spin debt covenants and more. Long-tail queries such as "Haleon executive stock transactions Form 4", "understanding Haleon SEC documents with AI", or "Haleon earnings report filing analysis" resolve to the exact section—no scrolling required.
All filing types are here, updated continuously: the Haleon annual report 10-K simplified (20-F), Haleon proxy statement executive compensation, and every Haleon 8-K material events explained. Use our tools to:
- Track insider buying and selling before marketing launches
- Compare vitamin and mineral supplement growth quarter-over-quarter
- Spot supply-chain disclosures in material event filings
Haleon plc announced the purchase of 5,150,000 ordinary shares of £0.01 each on 23 September 2025 as part of the second tranche of its share buyback programme. The company intends to hold the purchased shares as treasury shares.
After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 33,337,545 are treasury shares, leaving 8,919,016,103 ordinary shares with voting rights. The announcement includes a link to a full breakdown of individual trades and clarifies it is not an offer for securities.
Haleon plc announced the purchase of 5,150,000 ordinary shares under the second tranche of its share buyback programme. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 28,187,545 are held as treasury shares, leaving 8,924,166,103 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided London Stock Exchange link and on the Company website.
Haleon plc announced the purchase of 4,150,000 ordinary shares of £0.01 each on 19 September 2025 under the second tranche of its share buyback programme announced 31 July 2025. The shares were purchased on the London Stock Exchange and CBOE (UK)/CXE across the session; a full breakdown of individual trades is provided via the Company link. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 23,037,545 are treasury shares, leaving 8,929,316,103 voting shares.
Haleon plc reports it purchased 4,314,000 ordinary shares of £0.01 each under the second tranche of its buyback programme announced 31 July 2025. The company intends to hold the purchased shares as treasury shares. After settlement the company's registered share capital is 8,952,353,648 ordinary shares, of which 18,887,545 are treasury shares, leaving 8,933,466,103 ordinary shares with voting rights. Shareholders may use the voting-rights figure to determine notification obligations under the FCA Disclosure Guidance and Transparency Rules. A full breakdown of individual trades is available via the provided RNS link and on the company website.
Haleon plc completed a tranche of its share buyback programme, acquiring 5,214,540 ordinary shares (â£0.01 each) on 17 September 2025. The company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 14,573,545 are held in treasury, leaving 8,937,780,103 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on the company's investor website.
Haleon plc announced the purchase of 5,357,044 ordinary shares of £0.01 each under the second tranche of its buyback programme. The company will hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 9,359,005 are held in treasury, leaving 8,942,994,643 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided link and on the company's investor website. The announcement notes this does not constitute an offer for securities.
Haleon plc purchased 1,500,000 ordinary shares under the second tranche of its buyback programme announced 31 July 2025. The shares were bought on 15 September 2025 on the London Stock Exchange/CBOE (UK)/CXE and the company intends to hold the purchased shares as treasury shares.
After settlement the company's registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 4,001,961 are held as treasury shares, leaving 8,948,351,687 ordinary shares with voting rights. The announcement points investors to a full trade breakdown at the provided link and to Haleon's investor website for details.
Haleon plc announced on 15 September 2025 that it purchased 997,991 ordinary shares of each under the second tranche of its share buyback programme announced 31 July 2025. Of the purchased shares, 23,788 will be cancelled and 974,203 will be held as treasury shares. After settlement the company's registered share capital is 8,952,353,648 ordinary shares of each, with 2,501,961 held as treasury shares and 8,949,851,687 shares with voting rights.
The announcement notes a full trade breakdown is available via the provided RNS link and on the company's investor website.
Haleon plc reports the purchase and cancellation of 172,878 ordinary shares of £0.01 each under the second tranche of its share buyback programme announced 31 July 2025. Following settlement, registered share capital is 8,952,651,173 ordinary shares, of which 1,580,205 are held as treasury shares, leaving 8,951,070,968 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on the company website.
FAQ
What is the current stock price of Haleon (HLN)?
What is the market cap of Haleon (HLN)?
